Replies to post #234944 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

And Dr Bosch also basically said they were waiting on two more OS events at ASCO '17. And at the same ASCO '17 the Direct P2 in sarcoma was all a go for later in summer.

Even if we want to stick to the present storyline. LG said on a phone call back in Nov that they had 4 steps left to top line taking a couple months each, so you can just add them up.

I guess my calendar is broken.

[GoodGuyBill]

That's not it. Dr. Bosch, LP have said a lot of things over the past 4 years that turned out to be erroneous. After watching his ASCO presentation, I don't know what to make out of any of their statements.

I hope you are right...but given their track record, I can't take Dr. Bosch seriously considering that they have to coordinate with 4 regulatory agencies where any one could hold this trial up for any length of time. How can we take that seriously when the company can't even fill out a g-damn sec for on time once a year.

But...I hear you, flipper and hope you are right!

Keep hole alive!

Dr. Bosch stated basically everything (SAP draft/submission and data validation) was going to be completed in very little time compared to the five months that had already been put into the SAP by June 2, 2019. The unknown, he states, is how long regulator response to the SAP and possible ensuing dialogue might add to the process. That’s it.